SEC Form 4 · accession 0001209191-19-017840
REATA PHARMACEUTICALS INC · RETA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael D Wortley
Officer — Chief Legal Officer
Period of report
Mar 5, 2019
Accepted (ET)
Mar 7, 2019 · 5:22 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001358762
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A common stockF1 | Mar 5, 2019 | C | 26,940 | — | A | 26,940 | D | |
| Class A common stockF2 | Mar 5, 2019 | S | 8,489 | $98.6029 | D | 18,451 | D | |
| Class A common stockF3 | Mar 5, 2019 | S | 7,019 | $99.4756 | D | 11,432 | D | |
| Class A common stockF4 | Mar 5, 2019 | S | 5,041 | $100.425 | D | 6,391 | D | |
| Class A common stockF5 | Mar 5, 2019 | S | 300 | $101.6917 | D | 6,091 | D | |
| Class A common stockF6 | Mar 5, 2019 | S | 4,161 | $102.508 | D | 1,930 | D | |
| Class A common stockF7 | Mar 5, 2019 | S | 1,830 | $103.5419 | D | 100 | D | |
| Class A common stock | Mar 5, 2019 | S | 100 | $104.145 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F8,F1 | $11.00 | Mar 5, 2019 | M | 26,940 | D | — | May 25, 2026 | Class B common stock | 26,940 | 12,245 | D |
| Class B common stockF1 | — | Mar 5, 2019 | M | 26,940 | A | — | — | Class A common stock | 26,940 | 26,940 | D |
| Class B common stockF1 | — | Mar 5, 2019 | C | 26,940 | D | — | — | Class A common stock | 26,940 | 0 | D |
Explanation of responses
- F1The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $98.04 to $99.00. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $99.06 to $100.01. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
- F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $100.04 to $100.83. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
- F5The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $101.04 to $102.02. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
- F6The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $102.04 to $103.02. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
- F7The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $103.065 to $103.88. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
- F8The options, representing a right to purchase a total of 39,185 shares, vest in sixteen equal quarterly installments beginning on August 25, 2016.